Nilvadipine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Nilvadipine, covering 2017-03-06 to 2017-03-06. Get the full timeline:
Most recent: Clinical Trial Update: A Phase III Trial of Nilvadipine to Treat Alzheimer's Disease [Phase 3]